Form 4: QuidelOrtho EVP & COO Robert Bujarski Reports Stock Transactions
SEC Form 4 Filing
Robert Bujarski, EVP & COO of QuidelOrtho Corp, reports the acquisition and disposition of common stock and restricted stock units on October 15, 2024.
Summary
- On October 15, 2024, Robert Joseph Bujarski, EVP & COO of QuidelOrtho Corp, reported transactions involving the company's stock.
- He acquired 390 shares of common stock upon the release of restricted stock units.
- He also disposed of 217 shares to cover tax withholding obligations related to the release of these restricted stock units at a price of $40.2.
- Following these transactions, Bujarski directly owns 44,810 shares of QuidelOrtho common stock.
- Additionally, he holds 390 restricted stock units that vested on October 15, 2024, with another 390 shares scheduled to vest on October 15, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There are no indications of unusual or concerning activity.
Positives
- The vesting of restricted stock units indicates a form of compensation and alignment of the executive's interests with the company's performance.
Negatives
- The sale of shares to cover tax obligations, while common, slightly reduces the executive's holdings.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership changes.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term company performance, similar to practices at companies like Abbott Laboratories and Danaher Corporation.
- The sale of shares to cover tax obligations is a common practice among executives receiving stock-based compensation, mirroring behavior seen at peer companies such as Roche and Siemens Healthineers.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of stock acquisition and disposition, and vesting of 390 restricted stock units. |
| 10/17/2024 | Date of signature on the Form 4 filing. |
| 10/15/2025 | Date when the remaining 390 restricted stock units will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.